SOUTH SAN FRANCISCO, Calif., Aug. 23 MonogramBiosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, CEOand Chairman, is scheduled to present a corporate overview at the ThomasWeisel Partners Healthcare Conference 2007 on Wednesday, September 5, 2007 at3:15 p.m. (Eastern Time) at the Four Seasons Hotel in Boston, Massachusetts.
To access the live audio broadcast or the subsequent archived recording,log on to http://www.monogrambio.com and go to the investor relations section("Investors/Media" tab) and click on the "Events & Webcasts" link provided onthe sidebar menu on the page.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved antiviraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat www.monogrambio.com.Contacts: Alfred G. Merriweather Chief Financial Officer Tel: 650 624-4576 [email protected]
Jeremiah Hall Feinstein Kean Healthcare Tel: 415 677-2700 [email protected]
SOURCE Monogram Biosciences, Inc.